2024 annual financial data
First Tracks Biotherapeutics 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -181,101,000 USD and net income was -163,705,000 USD.
Operating cash flow was -125,806,000 USD.
Get free First Tracks Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -181,101,000 USD
- Net income
- -163,705,000 USD
- Operating cash flow
- -125,806,000 USD